FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34169311000001105: Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103593101000001114 Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106864601000001111 Memantine 5mg/10mg/15mg/20mg tablets treatment initiation pack (Lupin Healthcare (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) Is a Generic Ebixa tablets treatment initiation pack true Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) Has active ingredient Memantine hydrochloride true Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP false Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) 28 tablet 1 x (7tabs+7tabs+7tabs+7tabs) Has AMP True Memantine 5mg/10mg/15mg/20mg 4 week treatment initiation pack (Lupin (Europe) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start